Revenues from Contracts and Significant Customers (Narrative) (Details) - Dermatology Products Sales - Customer Concentration Risk [Member] - customer |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Revenue | |||
| Revenues from Contracts and Significant Customers | |||
| Number of customers | 0 | 0 | |
| Accounts Receivable | |||
| Revenues from Contracts and Significant Customers | |||
| Number of customers | 0 | 1 | |
| Customer One | Accounts Receivable | |||
| Revenues from Contracts and Significant Customers | |||
| Concentration risk, percentage | 10.30% | ||
| X | ||||||||||
- Definition Number of customers. No definition available.
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|